illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Carl Zeiss Meditec
Company logo

Carl Zeiss Meditec | Sustainability Performance

https://www.zeiss.com/meditec-ag/en/home.html

Develops and markets medical devices and solutions for ophthalmology and microsurgery applications.

2002

Germany

5,001 - 10,000 employees

Medical Device

$1B - 10B in revenue

$100M - 500M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#9162
Overall
#424
in Germany
#134
in Medical Device

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

141 out of 174

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projectionsAsset manager exclusion

View similiar companies


Company logo
Analytik Jena

Germany, Health Care, Medical Device


Company logo
Ottobock

Germany, Health Care, Medical Device


Company logo
Vetter Pharma

Germany, Health Care, Pharmaceuticals

Market cap

2.3B $, 2026▲111.5% YoY

Revenue

2.2B $, 2025▼7.2% YoY

R&D intensity

14.64% 2025

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Carl Zeiss Meditec AG, German major ophthalmology/microsurgery medical devices (Carl Zeiss Foundation 59% controlled, listed), has faced multiple US class actions over alleged inadequate disclosure of US/European ophthalmology customer demand normalization following the contested 2024 sustained share price volatility amid postCOVID ophthalmology customer demand normalization affecting German institutional shareholders amid global ophthalmology sector pressure.
Powered by illuminem

Market cap

2.3B $, 2026▲111.5% YoY

Revenue

2.2B $, FY2025▼7.2% YoY

EBITDA

223.0M $, FY2025▼9.1% YoY

Operating margin

10% Industry: -147▼6.1% YoY

P/E ratio

24.8 Industry: 32▼8.8% YoY

Revenue & EBITDA

$2.2BFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

133.3M 2025▼28.6% YoY

Capex

76.0M 2025▲100% YoY

Debt/equity ratio

0.3 Industry: 1▼NaN% YoY

R&D intensity

14.6%FY2025

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

5.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

2.1

▼ 1.4%

2023

2.1

▼ 1.1%

2024

2.2

▲ 0.3%

2025

2.9

2030

Powered by illuminem

Asset manager exclusions

1 2026▼NaN% YoY

Exclusions by region

Reveal data for 2 credits

Institutions excluding by region out of total tracked institutions

Powered by illuminem and Covalence

Excluding institutions

Reveal data for 2 credits

Institution name, type, screener label

Powered by illuminem and Covalence

Environmental policy coverage

Carbon reduction policy

Available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

7%
Independent Directors

1 out of 15 incl. management

Powered by illuminem

Overall score

85

Environment

99

Social

99

Governance

56

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees


Total sustainability employees

11+


    Available in
    Scale package

    Access
  • Email

  • Email